SELECTED PUBLICATIONS & RELEVANT INFORMATION
Q-Metrx actively carries out research and publishes on topics relevant to clinical neuroscience and psychology.
- Fava et al. (2016) A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients. Molecular Psychiatry.
- Brett A. English et al. (2014) Use of translational pharmacodynamic biomarkers in early-phase clinical studies for schizophrenia. Biomarkers Med.
- Nations et al. (2012) Examination of Org 26576, an AMPA receptor positive allosteric modultor, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial. Journal of Psychopharmacology.
- Shambroom, J.R., Fabregas, S.E. and Johnston, J. (2011) Validation of an automated wireless system to monitor sleep in healthy adults.Journal of Sleep Research.
- Johnstone, J. and Lunt, J. (2011) Use of Quantitative EEG to Predict Therapeutic Outcome in Neuropsychiatric Disorders. Neurofeedback and Neuromodulation Techniques and Applications.
- Johnstone J. and Gunkelman, J. (2003) Use of Databases in QEEG Evaluation. Journal of Neurotherapy.
Contact Form